FINWIRES · TerminalLIVE
FINWIRES

西卡重申2026年業績展望,市場低迷及匯率不利因素拖累季度銷售額

-- 儘管受全球建築市場低迷和匯率波動的影響,西卡(SIKA.SW)週二維持了其2026年的業績預期,但其第一季以瑞士法郎計價的銷售額同比下降了7%。 這家瑞士特種化學品集團截至3月31日的第一季淨銷售額為24.9億瑞士法郎,低於去年同期的26.8億瑞士法郎。該銷售額高於FactSet匯總的24.5億瑞士法郎的普遍預期。 以當地貨幣計算,得益於所有地區市佔率的成長,銷售額小幅成長0.9%。隨著冬季過後建築活動的復甦,歐洲、中東和非洲的銷售額增速從0.7%加快至3.6%。然而,受冬季風暴和經濟不確定性的影響,美洲地區的銷售額在經歷了2025年第一季4.9%的成長後,下降了0.8%。受中國建築業務兩位數下滑的影響,亞太地區銷售額也下降了2.2%。 儘管西卡公司預測2026年全球市場狀況疲軟,包括出現個位數百分比的下滑,但預計在經歷了上半年疲軟之後,建築業的成長動能將逐步改善。因此,該公司維持其2026年以當地貨幣計算的銷售額成長1%至4%的預期,與該公司力爭超越市場3%至6%的目標一致。西卡公司也確認了其在「2028戰略」框架下實現「可持續盈利」成長的中期戰略目標。 此外,作為「快速前進計畫」(Fast Forward program)的一部分,西卡公司在中國進行了有針對性的結構調整,並在其他市場實施了營運改善。該計畫預計在2026年實現8,000萬瑞士法郎的成本節約,並在2028年全面實施後,每年實現1.5億至2億瑞士法郎的成本節約。 “我們正在加快產品創新方面的投資,並提升客戶價值主張,”首席執行官托馬斯·哈斯勒表示,“我們密切關注中東局勢的影響。我們預計2026年全球市場環境將保持低迷,因此我們正在採取先發製人的措施。”

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB